|drug563||CIG Axial Wiki||1.00|
|drug972||DIG Axial Wiki||1.00|
|drug564||CIG Tilted Wiki||1.00|
There is one clinical trial.
Fifty six patients were randomly enrolled in the study. Participants were randomly stratified into two control groups and two test groups, from which conventional pick up and digital impressions were made respectively. Patients of group 1 (CIG Axial) and 3 (DIG Axial) received 4 axial implants whereas, group 2 patients (CIG Tilted), and group 4 (DIG Tilted) received two anterior axial implants and two distal tilted implants. All participants received hybrid dentures. Bone loss, implant loss, maintenance of prosthesis were evaluated at 6m,12m, and 24 months follow up period.
Description: periimplant bone loss was measuredMeasure: bone loss Time: 24 months
Description: the loss of implants was evaluated through the follow up periodMeasure: implant loss Time: 24 months
Description: screw loosening, screw fracture, framework fracture, fracture of teeth, remake of the prosthesis , and fracture of acrlyic resin were evaluatedMeasure: maintenance Time: 24 months
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports